Sang-Oh Yoon and Sejeong Shin, both from the Department of Physiology and Biophysics, were awarded $25K for their project entitled "Discovery of small-molecule LRP6 inhibitors for cancer therapy.”
Xue-Jun Li (Medicine, Rockford) and Duncan Wardrop (CHEM) were awarded a $25K Launch award for their project entitled “Identification of small-molecule therapeutics using human stem cell models of Charcot-Marie-Tooth disease.”
Alexander (Shura) Mankin, Paul Carlier and Max Svetlow were awarded an MPI R21 grant (AI196497) entitled ““Identifying inhibitors of the bacterial peptidyl-tRNA hydrolase”
Larry Miller (CHEM), Xiaojing Yang (CHEM) and Mark McCauley) were awarded a $25K Launch award for their project entitled “Development of a Ligand-binding assay for the PP1Cβ:PPP1212C phosphatase complex.”
Ekrem Emrah Er (Physiology and Biophysics) and Terry Moore (Pharmaceutical Sciences) were awarded a $25K U2D2 award for their project entitled “Discovery of ISGylation Inhibitors for Breast Cancer Metastasis and Immune Modulation”
UICentre announces a collaboration with the Center for Clinical and Translational Science (CCTS) to fund new drug discovery projects.
In Round 1 (February 2024), two awards of $30K were made.
In Round 2 (October 2024), one award of $50K was made.
The UICentre and the UI Cancer are continuing their collaboration to provide seed grants ($25K each) for promising new cancer therapeutic approaches. Today we announce our second round of awards, which are directed…
In Fall 2022, the University of Illinois Cancer Center (UICC) and UICentre joined forces to launch a new cancer drug discovery RFA entitled “U2D2”. Today we are announcing our first $25K awards: Identification…
Paul Carlier is the new director of UICentre, UIC's campus-wide drug discovery initiative that supports translational, "bench to bedside" scientific research. He also joins the Departments of Pharmaceutical Sciences & Chemistry as professor.
